Ireland· IE-PA-EU/1/18/1293/001-003
Aimovig 70 mg Solution for injection
A other antimigraine preparations product containing erenumab, registered in Ireland by Novartis Europharm Limited. The same ATC class is registered in 5 of our 19 countries.
Checked against HPRA (Ireland) on
Informational only — not a medical device.
Where it is registered
Erenumab is registered in 5 of 19 countries.
Countries holding a registration under ATC N02CX (other antimigraine preparations), each read from that country’s own register.
- This record: Ireland, from HPRA (Ireland)
- 3 of them publish a price we can compare per daily dose
Erenumab · ATC N02CX
5 / 19 countries
- Denmark
- Finlandprice
- Ireland
- Norwayprice
- Switzerlandprice
The record
At a glance
HPRA (Ireland)- Active substance
- ERENUMAB
- Manufacturer
- Novartis Europharm Limited
- Country
- Ireland (IE)
- ATC code
- N02CX
- ATC class
- Other antimigraine preparations
- Reimbursed
- Not published by this register
- Source register
- HPRA (Ireland)
- Last checked
- September 28, 2026
Packs & prices · 1
- ie_pa_numberEU/1/18/1293/001-003
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Erenumab in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaAIMOVIGNovartis Europharm Limited, Dublin
- BelgiumAimovig 70 mgNovartis Europharm
- IcelandAimovigNovartis Europharm Limited*
- SwedenAimovig 70 mg Injektionsvätska, lösning i förfylld injektionspennaNovartis Europharm Limited
- SpainAIMOVIG 70 MG SOLUCION INYECTABLE EN PLUMA PRECARGADANovartis Europharm Limited
- United KingdomAimovig 70mg/1ml solution for injection pre-filled pensNovartis Pharmaceuticals UK Ltd
- United StatesAIMOVIGAmgen, Inc
- FinlandAimovigParanova Oy
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Aimovig
- Liechtenstein · Aimovig
- Norway · Aimovig
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/c014272b-ccd6-4108-81dc-e20a16196213 GET /v1/drugs/c014272b-ccd6-4108-81dc-e20a16196213?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Solution for injection",
"routes": null,
"source": "hpra",
"atc_all": [
"N02CX"
],
"strength": null,
"pa_number": "EU/1/18/1293/001-003",
"substances": [
"ERENUMAB"
],
"legal_basis": "Known active substance (Article 8(3) of Directive No 2001/83/EC)",
"market_info": "Unknown",
"authorised_at": "26/07/2018",
"dispensing_status": "Product subject to prescription which may not be renewed (A)",
"registration_status": "AU",
"supply_legal_status": "Supply through pharmacies only",
"interchangeable_code": null
}See everything about erenumab.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.